COVID-19 and Medical Biotechnology.
作者信息
Rezaei Nima
机构信息
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Avicenna J Med Biotechnol. 2020 Jul-Sep;12(3):139.
Abstract
摘要
相似文献
1
COVID-19 and Medical Biotechnology.
Avicenna J Med Biotechnol. 2020 Jul-Sep;12(3):139.
2
Insights from Pharmaceutical Biotechnology into Phenolic Biopharmaceuticals against COVID-19.
Curr Pharm Biotechnol. 2021 Oct 6;22(14):1848-1856. doi: 10.2174/1389201021666201104144509.
3
Inclusion of COVID-19 as a topic in an undergraduate biotechnology course.
Biochem Mol Biol Educ. 2022 Nov;50(6):631-632. doi: 10.1002/bmb.21670. Epub 2022 Aug 27.
4
Exploring the use of virtual laboratory simulations before, during, and post COVID-19 recovery phase: An Animal Biotechnology case study.
Biochem Mol Biol Educ. 2021 Sep;49(5):685-691. doi: 10.1002/bmb.21562. Epub 2021 Jul 22.
5
COVID-19 Crisis: How Can Plant Biotechnology Help?
Plants (Basel). 2021 Feb 12;10(2):352. doi: 10.3390/plants10020352.
6
Monoclonal Antibodies vs COVID-19: Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center.
MEDICC Rev. 2021 Apr;23(2):12. doi: 10.37757/MR2021.V23.N2.17. Epub 2021 Apr 30.
7
Agricultural biotechnology for sustainable food security.
Trends Biotechnol. 2023 Mar;41(3):331-341. doi: 10.1016/j.tibtech.2022.12.013. Epub 2023 Jan 27.
8
Challenges and Opportunities for the Biotechnology Research Community during the Coronavirus Pandemic.
Trends Biotechnol. 2020 Aug;38(8):823-824. doi: 10.1016/j.tibtech.2020.04.016. Epub 2020 May 7.
9
Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.
Front Bioeng Biotechnol. 2022 Jul 4;10:939295. doi: 10.3389/fbioe.2022.939295. eCollection 2022.
10
Medical biotechnology trends and achievements in iran.
Avicenna J Med Biotechnol. 2012 Oct;4(4):200-5.
引用本文的文献
1
Mental Healthcare in Pediatrics During the COVID-19 Pandemic: A Call for International Public Health Action.
Adv Exp Med Biol. 2024;1458:19-34. doi: 10.1007/978-3-031-61943-4_2.
2
Computed tomography scan in COVID-19: a systematic review and meta-analysis.
Pol J Radiol. 2022 Jan 5;87:e1-e23. doi: 10.5114/pjr.2022.112613. eCollection 2022.
3
Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.
Eur J Pharmacol. 2021 Sep 5;906:174248. doi: 10.1016/j.ejphar.2021.174248. Epub 2021 Jun 12.
4
Health and Art (HEART): Integrating Science and Art to Fight COVID-19.
Adv Exp Med Biol. 2021;1318:937-964. doi: 10.1007/978-3-030-63761-3_53.
5
Interdisciplinary Approaches to COVID-19.
Adv Exp Med Biol. 2021;1318:923-936. doi: 10.1007/978-3-030-63761-3_52.
6
Socialization During the COVID-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing.
Adv Exp Med Biol. 2021;1318:911-921. doi: 10.1007/978-3-030-63761-3_51.
7
A Borderless Solution Is Needed for A Borderless Complexity, Like COVID-19, the Universal Invader.
Adv Exp Med Biol. 2021;1318:891-910. doi: 10.1007/978-3-030-63761-3_50.
8
COVID-19 and Its Global Economic Impact.
Adv Exp Med Biol. 2021;1318:825-837. doi: 10.1007/978-3-030-63761-3_46.
9
Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the COVID-19 Pandemic.
Adv Exp Med Biol. 2021;1318:687-703. doi: 10.1007/978-3-030-63761-3_38.
10
Prevention of COVID-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions.
Adv Exp Med Biol. 2021;1318:575-604. doi: 10.1007/978-3-030-63761-3_32.
本文引用的文献
1
The immune system and COVID-19: Friend or foe?
Life Sci. 2020 Sep 1;256:117900. doi: 10.1016/j.lfs.2020.117900. Epub 2020 Jun 2.
2
COVID-19: Transmission, prevention, and potential therapeutic opportunities.
Clin Chim Acta. 2020 Sep;508:254-266. doi: 10.1016/j.cca.2020.05.044. Epub 2020 May 29.
3
The urgent need for integrated science to fight COVID-19 pandemic and beyond.
J Transl Med. 2020 May 19;18(1):205. doi: 10.1186/s12967-020-02364-2.
4
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.
Int Immunopharmacol. 2020 Jul;84:106560. doi: 10.1016/j.intimp.2020.106560. Epub 2020 May 8.
5
COVID-19: Developing from an Outbreak to A Pandemic.
Arch Med Res. 2020 Aug;51(6):582-584. doi: 10.1016/j.arcmed.2020.04.021. Epub 2020 May 13.
6
All together to Fight COVID-19.
Am J Trop Med Hyg. 2020 Jun;102(6):1181-1183. doi: 10.4269/ajtmh.20-0281.
7
Borderless collaboration is needed for COVID-19-A disease that knows no borders.
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1245-1246. doi: 10.1017/ice.2020.162. Epub 2020 Apr 22.
8
Immune-epidemiological parameters of the novel coronavirus - a perspective.
Expert Rev Clin Immunol. 2020 May;16(5):465-470. doi: 10.1080/1744666X.2020.1750954. Epub 2020 Apr 6.
Zotero 插件